Sugar-Based Immune Adjuvants for Use in Recombinant, Viral Vector, DNA and Other Styles of Vaccines
Author:
Petrovsky Nikolai
Publisher
Springer Vienna
Reference117 articles.
1. Ara Y, Saito T, Takagi T, Hagiwara E, Miyagi Y, Sugiyama M, Kawamoto S, Ishii N, Yoshida T, Hanashi D, Koshino T, Okada H, Okuda K (2001) Zymosan enhances the immune response to DNA vaccine for human immunodeficiency virus type-1 through the activation of complement system. Immunology 103(1):98–105 2. Arca HC, Gunbeyaz M, Senel S (2009) Chitosan-based systems for the delivery of vaccine antigens. Expert Rev Vaccines 8(7):937–953 3. Archambault D, Morin G, Elazhary Y (1988) Influence of immunomodulatory agents on bovine humoral and cellular immune responses to parenteral inoculation with bovine rotavirus vaccines. Vet Microbiol 17(4):323–334 4. Azuma I, Okumura H, Saiki I, Kiso M, Hasegawa A, Tanio Y, Yamamura Y (1981) Adjuvant activity of carbohydrate analogs of N-acetylmuramyl-L-alanyl-D-isoglutamine on the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs. Infect Immun 33(3):834–839 5. Bachelder EM, Beaudette TT, Broaders KE, Frechet JM, Albrecht MT, Mateczun AJ, Ainslie KM, Pesce JT, Keane-Myers AM (2010) In vitro analysis of acetalated dextran microparticles as a potent delivery platform for vaccine adjuvants. Mol Pharm 7(3):826–835
|
|